1. Home
  2. Search Clinical Trials
Search
Filters
Clear All
  • 49
  • 59
  • 6
  • 3
  • 497

Phase

  • 18
  • 14
  • 3
  • 14
  • 6
  • 15
  • 2
  • 439
  • 580
  • 230
  • 603
  • 11
  • 53
  • 26
  • 6
  • 608

Found 614 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:

A Phase II Study of Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer: Big Ten Cancer Research Consortium BTCRC-LUN17-139

18 years - 100 years
All genders
The purpose of this study is to estimate the progression free survival (PFS) of the combination of Carboplatin plus Pemetrexed plus Atezolizumab plus Bevacizumab for patients with stage IV non-squamous NSCLC who are chemotherapy and immunotherapy naive.
Learn More
The Hoosier Moms Cohort

The Hoosier Moms Cohort

18 years - 100 years
Female
Phase 1
The purpose of this study is to better understand how Gestational Diabetes Mellitus (GDM, high blood sugar in pregnancy) develops. We hope to understand the differences between women who are diagnosed with GDM and those who are not. Another purpose is to understand how GDM can progress to Type 2 …
Learn More

Enhancing Prospective Thinking in Early Recovery

21 years - 50 years
All genders
The purpose of this study is to better understand what factors, demographic characteristics, and interventions predict better recovery-related outcomes.
Learn More

A Phase II Trial of Atezolizumab plus Chemotherapy after Progression on Single Agent PD-1 or PD-L1 Inhibitor in Cisplatin-ineligible Patients with Advanced Urothelial Carcinoma

18 years - 100 years
All genders
The purpose of this study is to compare any good and bad effects of using Atezolizumab along with the usual chemotherapy after progression with PD-1 or PD-L1 Inhibitor for individuals with urothelial carcinoma (cancer of the urinary tract).
Learn More
The Beef and Heart Health Study

The Beef and Heart Health Study

a
app tester
30 years - 69 years
Accepts healthy volunteer
All genders
The purpose of this study is to assess the effect of substituting predominantly starchy vegetables and refined grains with 6 oz/day of lean unprocessed beef in the USDA's Healthy Vegetarian Eating Patter on cardio metabolic risk factors in healthy adults.
Learn More

A Window into Schizophrenia: Evaluating Social Dysfunction Using Real-World Audio Recordings

18 years - 60 years
Accepts healthy volunteer
All genders
The purpose of this study is to measure social functioning in the everyday life of people with schizophrenia and healthy controls (people without schizophenia) .
Learn More

A Phase I/II, Open-Label Study to Investigate the Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics of GSK3145095 Administered Alone and in Combination With Anticancer Agents Including Pembrolizumab in Adult Participants With Selected Advanced Solid Tumors

18 years - 100 years
All genders
In an unbiased CRISPR screen, RIPK1 was identified as a top gene contributing to immunotherapy resistance. In addition, RIPK1 has been reported to drive pancreatic oncogenesis. In murine models, inhibition of RIPK1 kinase activity in the pancreatic tumor microenvironment leads to the replacement of tumor-permissive myeloid infiltrates with innate cells …
Learn More

Managed Access Program (MAP) to Provide Access to CTL019, for ALL or DLBCL Patients With Out of Specification Leukapheresis Product and/or Manufactured Tisagenlecleucel Out of Specification for Commercial Release

100 years or below
All genders
The purpose of this Managed Access Program (MAP) Treatment Plan is to provide access to CTL019, for acute lymphoblastic leukemia (ALL) or diffuse large b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release where no overwhelming safety concerns has been …
Learn More

A Phase 2 Study of Veliparib (ABT-888) and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients With Newly Diagnosed High-Grade Glioma (HGG) Without H3 K27M or BRAFV600E Mutations

3 years - 25 years
All genders
This phase II trial studies how well veliparib, radiation therapy, and temozolomide work in treating participants with newly diagnosed malignant glioma without H3 K27M or BRAFV600E mutations.
Learn More

A Randomized Phase 2 Trial of Axitinib/Nivolumab Combination Therapy vs. Single Agent Axitinib or Nivolumab for the Treatment of TFE/Translocation Renal Cell Carcinoma (tRCC) Across All Age Groups

1 years - 100 years
All genders
This phase II trial studies how well axitinib and nivolumab works in treating patients with TFE/translocation renal cell carcinoma that cannot be removed by surgery or has spread to other places in the body.
Learn More
351 - 360 of 614